Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A cash flow conversion efficiency. Based on the latest financial reports, Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.57 Million ≈ $2.28 Million USD) by net assets (CN¥5.73 Billion ≈ $838.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2025)

Cash flow conversion efficiency of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2011 to 2025. This chart illustrates how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Wuhan Easy Diagnosis Biomedicine Co Ltd share price for real-time trading data and today's change.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Cash Flow Conversion Ratio Explained

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A ranked by their cash flow conversion efficiency. Also see 002932 company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Huali Industries
SHG:603038
-0.005x
Weyco Group Inc
NASDAQ:WEYS
0.030x
Gansu Golden Glass Technologies Co Ltd
SHE:300093
0.043x
Zhejiang Tiancheng Control Co
SHG:603085
0.100x
Ponce Financial Group Inc
NASDAQ:PDLB
0.014x
Hangzhou Anysoft Information Technology Co Ltd
SHE:300571
0.066x
Masoval AS
OL:MAS
0.159x
Gemtek Technology Co Ltd
TW:4906
0.095x

Annual Cash Flow Conversion Efficiency for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2025)

The table below shows the annual cash flow conversion efficiency of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2011 to 2025. Review 002932 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.66 Billion
≈ $827.62 Million
CN¥-70.05 Million
≈ $-10.25 Million
-0.012x +12.34%
2024-12-31 CN¥6.02 Billion
≈ $880.72 Million
CN¥-85.05 Million
≈ $-12.44 Million
-0.014x -122.65%
2023-12-31 CN¥6.29 Billion
≈ $920.73 Million
CN¥392.50 Million
≈ $57.43 Million
0.062x -89.47%
2022-12-31 CN¥6.77 Billion
≈ $990.93 Million
CN¥4.01 Billion
≈ $587.21 Million
0.593x +49.86%
2021-12-31 CN¥2.85 Billion
≈ $417.06 Million
CN¥1.13 Billion
≈ $164.92 Million
0.395x +22.57%
2020-12-31 CN¥1.11 Billion
≈ $163.14 Million
CN¥359.68 Million
≈ $52.63 Million
0.323x +783.28%
2019-12-31 CN¥615.62 Million
≈ $90.08 Million
CN¥22.49 Million
≈ $3.29 Million
0.037x -59.67%
2018-12-31 CN¥592.59 Million
≈ $86.72 Million
CN¥53.67 Million
≈ $7.85 Million
0.091x -52.68%
2017-12-31 CN¥242.93 Million
≈ $35.55 Million
CN¥46.50 Million
≈ $6.80 Million
0.191x -43.07%
2016-12-31 CN¥175.08 Million
≈ $25.62 Million
CN¥58.86 Million
≈ $8.61 Million
0.336x -13.84%
2015-12-31 CN¥115.39 Million
≈ $16.89 Million
CN¥45.02 Million
≈ $6.59 Million
0.390x +17.45%
2014-12-31 CN¥49.59 Million
≈ $7.26 Million
CN¥16.47 Million
≈ $2.41 Million
0.332x -28.26%
2013-12-31 CN¥13.60 Million
≈ $1.99 Million
CN¥6.30 Million
≈ $921.32K
0.463x -36.17%
2012-12-31 CN¥1.42 Million
≈ $208.28K
CN¥1.03 Million
≈ $151.10K
0.725x +103.22%
2011-12-31 CN¥21.45K
≈ $3.14K
CN¥-482.90K
≈ $-70.66K
-22.514x --

About Wuhan Easy Diagnosis Biomedicine Co Ltd Class A

SHE:002932 China Medical Devices
Market Cap
$491.32 Million
CN¥3.36 Billion CNY
Market Cap Rank
#12000 Global
#3417 in China
Share Price
CN¥14.44
Change (1 day)
+0.14%
52-Week Range
CN¥13.85 - CN¥20.47
All Time High
CN¥49.58
About

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents and diagnostic instruments in China. The company offers external diagnostic testing, third-party medical testing, certification consulting services, and medical information platform construction services. It also provides information software and supporting hardware… Read more